Literature DB >> 7074649

Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP.

F B Hagemeister, L M Fuller, W S Velasquez, J A Sullivan, L North, J J Butler, D A Johnston, C C Shullenberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7074649

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  6 in total

1.  Radiation therapy alone versus radiation therapy and chemotherapy in the management of Hodgkin's disease.

Authors:  L D Glenn; P P Kumar
Journal:  J Natl Med Assoc       Date:  1990-02       Impact factor: 1.798

Review 2.  Early-stage Hodgkin's disease: current approaches to treatment.

Authors:  J J Rusthoven; R MacKenzie
Journal:  Can Med Assoc J       Date:  1985-08-01       Impact factor: 8.262

Review 3.  Current management of Hodgkin's disease.

Authors:  B C Behrens; R C Young; V T DeVita
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

4.  Staging laparotomy with splenectomy for Hodgkin's disease: the Stanford experience.

Authors:  M A Taylor; H S Kaplan; T S Nelsen
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

Review 5.  Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk.

Authors:  J G Franklin; M D Paus; A Pluetschow; L Specht
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

6.  Chromosomal damage in sperm of patients surviving Hodgkin's disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy.

Authors:  B F Brandriff; M L Meistrich; L A Gordon; A V Carrano; J C Liang
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.